Joint bookrunners Jefferies, BMO and Piper Jaffray to conduct offering
By Devika Patel
Knoxville, Tenn., June 25 – Amphastar Pharmaceuticals, Inc. said it priced its $32.48 million initial public offering of stock with an $8.4 million greenshoe. The deal will include a $23.52 million secondary sale.
The company will sell 4.64 million common shares at $7.00 per share. In addition, 3.36 million shares will be sold by shareholders.
Jefferies LLC, BMO Capital Markets Corp. and Piper Jaffray & Co. are the joint bookrunning managers.
Settlement is expected June 30.
Proceeds will be used for product development, working capital and other general corporate purposes, as well as potential acquisitions.
Rancho Cucamonga, Calif.-based Amphastar is a generic and specialty pharmaceutical company that focuses on injectable and inhalation products. It expects its shares to trade on the Nasdaq under the symbol “AMPH.”
Issuer: | Amphastar Pharmaceuticals, Inc.
|
Issue: | Common stock
|
Amount: | $32.48 million
|
Greenshoe: | $8.4 million
|
Shares: | 4.64 million
|
Price: | $7.00
|
Warrants: | No
|
Bookrunners: | Jefferies LLC, BMO Capital Markets Corp. and Piper Jaffray & Co.
|
Pricing date: | June 25
|
Settlement date: | June 30
|
Stock symbol: | Nasdaq: AMPH
|
|
© 2015 Prospect News.
All content on this website is protected by copyright law in the U.S. and elsewhere.
For the use of the person downloading only.
Redistribution and copying are prohibited by law without written permission in advance from Prospect News.
Redistribution or copying includes e-mailing, printing multiple copies or any other form of reproduction.